Suresh K. Durgam
CIK 1829958 · EVP, Chief Medical Officer · last filed 2025-04-02
Suresh K. Durgam is an EVP, Chief Medical Officer who has filed 25 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for ITCI, was dated Apr 2, 2025. Across all open-market trades the lifetime net is −$10.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
25
-$10.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | EVP, Chief Medical Officer | 0 | $131.87 | $0 | -$10.05M | 25 | 2025-04-02 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | −42,913 | -$5.66M | EDGAR |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +11,790 | -$1.14M | EDGAR |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +5,033 | -$475.5K | EDGAR |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +6,287 | -$600.7K | EDGAR |
| 2024-03-11 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | −2,817 | -$672.8K | EDGAR |
| 2024-03-08 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +13,132 | $0 | EDGAR |
| 2024-03-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +3,795 | -$288.5K | EDGAR |
| 2024-02-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +5,693 | -$414.4K | EDGAR |
| 2024-01-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$3.16M | EDGAR |